Clinical Research Directory
Browse clinical research sites, groups, and studies.
Implementation of Precision Medicine in High-risk Prostate Cancer
Sponsor: Andreas Josefsson
Summary
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
Official title: Swedish Prostate Cancer Initiative for Novel Treatment Regimens - Real, Implementation of Precision Medicine in High-risk Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5500
Start Date
2024-06-10
Completion Date
2054-12
Last Updated
2025-09-03
Healthy Volunteers
No
Conditions
Interventions
High-risk treatment SOC
radiotherapy (RT) + ADT (3 years) + Abiraterone acetate (2 years), with radical prostatectomy being an option if contraindication for RT exists)
Active monitoring
Followed with PSA measurements
Radical prostatectomy
Radical prostatectomy
Radiotherapy
Radiotherapy
Androgen deprivation therapy
GnRH agonist + abiraterone acetate/enzalutamide and/or docetaxel
Locations (1)
Urology, Umeå University Hospital, Region Västerbotten
Umeå, Sweden